Refine
Year of publication
Document Type
- Article (64)
- Part of a Book (7)
- Conference Proceeding (6)
- Preprint (2)
- Doctoral Thesis (1)
- Habilitation (1)
Language
- English (54)
- German (26)
- Multiple languages (1)
Has Fulltext
- yes (81)
Is part of the Bibliography
- no (81)
Keywords
- wassergefiltertes Infrarot A (wIRA) (25)
- Gewebetemperatur (21)
- Gewebedurchblutung (20)
- Wundheilung (20)
- Sauerstoffpartialdruck im Gewebe (19)
- Schmerzminderung (19)
- water-filtered infrared-A (wIRA) (18)
- Infektionsabwehr (16)
- reduction of pain (15)
- tissue oxygen partial pressure (15)
- tissue temperature (15)
- Infrarot (14)
- Sauerstoffversorgung (14)
- tissue blood flow (14)
- Entzündung (13)
- Schmerz (12)
- Lebensqualität (10)
- wound healing (10)
- Energieumsatz <Medizin> (9)
- Energiebereitstellung (8)
- Problemwunden (8)
- Wunde (8)
- Wundinfektion (8)
- Wundinfektionen (8)
- Wundsekretion (8)
- energy supply (8)
- inflammation (8)
- oxygen supply (8)
- problem wounds (8)
- quality of life (8)
- wound infections (8)
- Sekretion (7)
- thermal and non-thermal effects (7)
- thermische und nicht-thermische Effekte (7)
- wound exudation (7)
- acute wounds (6)
- akute Wunden (6)
- chronische venöse Unterschenkel-Ulzera (6)
- infection defense (6)
- temperaturabhängige und temperaturunabhängige Effekte (6)
- thermic and non-thermic effects (6)
- visuelle Analogskalen (VAS) (6)
- Hyperthermie (5)
- chronic venous stasis ulcers of the lower legs (5)
- prospective, randomized, controlled, double-blind studies (5)
- prospektive, randomisierte, kontrollierte, doppeltblinde Studien (5)
- Infrarot-Thermographie (4)
- Regeneration (4)
- Sportmedizin (4)
- contact-free method (4)
- infrared thermography (4)
- kontaktfreies, verbrauchsmaterialfreies Verfahren (4)
- thermographic image analysis (4)
- thermographische Bildanalyse (4)
- Gewichtsabnahme (3)
- Infrarot-A-Strahlung (3)
- Training (3)
- absent expenditure of material (3)
- immunmodulierende Effekte (3)
- immunomodulatory effects (3)
- infrared-A radiation (3)
- visual analog scales (VAS) (3)
- visual analogue scales (VAS) (3)
- Analyse der Körperzusammensetzung (2)
- Bewegungsmangel (2)
- Cholesterin (2)
- Fettstoffwechsel (2)
- Fußkurbelergometerausdauerbelastung (2)
- High-density-Lipoproteine HDL (2)
- Interventionsversuch (2)
- Körpergewicht (2)
- Körpermasseindex BMI (2)
- Laktat (2)
- Lipolyse (2)
- Low-density-Lipoproteine LDL (2)
- Physikalische Medizin (2)
- Physikalische Therapie (2)
- Prävention (2)
- Sauerstoff (2)
- Triglyzeride (2)
- analysis of body composition (2)
- bicycle ergometer endurance exercise (2)
- body mass index BMI (2)
- body weight (2)
- cholesterol (2)
- chronic wounds (2)
- chronische Wunden (2)
- high density lipoproteins HDL (2)
- intervention trial (2)
- lactate (2)
- lipid metabolism (2)
- lipolysis (2)
- local fat reduction (2)
- lokale Fettabnahme (2)
- low density lipoproteins LDL (2)
- randomised controlled study (2)
- randomisierte kontrollierte Studie (2)
- tetrapolar bioimpedance analysis (2)
- tetrapolare Bioimpedanzanalyse (2)
- triglycerides (2)
- wIRA (2)
- weight reduction (2)
- 5-Aminolävulinsäure (5-ALA) (1)
- 5-aminolevulinic acid (5-ALA) (1)
- ADHD (1)
- Abnahme einer Hypersekretion (1)
- Abnahme vermehrter Speichelbildung (1)
- Abnahme von Schleimbildung (1)
- Abweichungen (1)
- Aikido (1)
- Akupressur (1)
- Akupunktur (1)
- Allokation der Ressourcen (1)
- Arznei- und Heilmittelrichtlinie (1)
- Arzneimittel (1)
- Augenheilkunde (1)
- Augenverletzungen (1)
- Ausdauertraining (1)
- Ayurveda (1)
- Beckenschiefstand (1)
- Befinden (1)
- Beurteilungen (1)
- Bewegung (1)
- Bewertungen (1)
- Bildgebung (1)
- CNVs (1)
- Cerebral toxoplasmosis HIV (1)
- Chinesische Medizin (1)
- Computer-Tomographie (CT) gesteuerte Verfahren (1)
- Corneometrie (1)
- Curcumin (1)
- Declaration of Cologne (1)
- Definition Gesundheit (1)
- Dehnen verkürzter Muskulatur (1)
- Dermatologie (1)
- Dermatopharmakokinetik (1)
- Diagnosis (1)
- Doping (1)
- Eisenstoffwechsel (1)
- Entsäuerung (1)
- Epigenetik (1)
- Ernährung (1)
- Ethik (1)
- Evidence based medicine (1)
- Evidenzbasierte Medizin (1)
- Farbstoff (1)
- Fehlstatik (1)
- Finanzierung (1)
- Fitness (1)
- Fitnesscenter (1)
- Fluoreszein (1)
- Flüssigkeit (1)
- Funktionsdefizite (1)
- Fédération Internationale de Médicine du Sport (FIMS) (1)
- GWAS (1)
- Gehirn (1)
- Genetics (1)
- Gesundheitswirtschaft (1)
- Gewebe-Sauerstoffpartialdruck (1)
- Gewebesauerstoffpartialdruck (1)
- HNO (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hautbarriere (1)
- Hautoberflächentemperatur (1)
- Herzinfarkt (1)
- Humankapital (1)
- Hydratation der Epidermis (1)
- Hyperbare Oxygenation (HBO) (1)
- Immunogenetics (1)
- Immunology (1)
- Implantatverfahren (1)
- Infrarot-A-Strahlung (IRA) (1)
- Infrarot-Ganzkörperhyperthermie (1)
- Injektionstherapie (1)
- Integrationsversorgung/integrierte ambulante Versorgung (1)
- Kalorienverbrauch (1)
- Kontroll- und Regressmechanismen (1)
- Kosten-Nutzen-Analyse (1)
- Krankengymnastik (1)
- Kölner Deklaration (1)
- Körperliche Belastung (1)
- Laser-Scan-Mikroskopie (1)
- Late presentation (1)
- Lebensstiländerung (1)
- Leistung (1)
- Leistungsfähigkeit (1)
- Leistungssteigerung (1)
- Leitlinien (1)
- Lichtalterung (1)
- MRP4 (1)
- Magnetfeldresonanztherapie (1)
- Massage (1)
- Massage (chinesische / japanische / ayurvedische / indische / indonesische / javanesische / balinesische Massage) (1)
- Matrix metalloproteinase 1 (MMP-1) (1)
- Matrix-Metalloproteinase 1 (MMP-1) (1)
- Matrix-Rhythmus-Therapie (1)
- Mikrostromtherapie (1)
- Muskulatur (1)
- Nahrungsergänzungsmittel (1)
- Neurochirurgie (1)
- Ohrakupunktur (1)
- Okklusivverband (1)
- Onkologie (1)
- Opportunistic infections (1)
- PARK2 (1)
- PCP (1)
- PGE2 (1)
- Pathophysiologie (1)
- Penetration (1)
- Penetrationsverstärker (1)
- Pharmakoepidemiologie (1)
- Photodynamische Therapie (PDT) (1)
- Physiotherapie (1)
- Pneumocystis jirovecii (1)
- Priorisierung in der Medizin (1)
- Präventivmedizin (1)
- Psyche (1)
- Psychiatric disorders (1)
- Psychotherapie (1)
- Rationalisierung (1)
- Rationierung (1)
- Regelleistungsvolumen (1)
- Rehabilitation (1)
- Risikofaktor (1)
- Routinedaten (1)
- Rückenschmerz (1)
- Rückenschmerzen (1)
- Rückentraining (1)
- Sauerstoffpartialdruck (1)
- Schmerztherapie (1)
- Shiatsu (1)
- Skoliose (1)
- Sozialgesetzbuch V (1)
- Spektroskopie (1)
- Sport (1)
- Sport pro Gesundheit (1)
- Sportler (1)
- Sportliche Leistungsfähigkeit (1)
- Sportophthalmologie (1)
- Sportärztekongress (1)
- Stratum corneum (1)
- Substitution (1)
- Supplementierung (1)
- Taekwondo (1)
- Taekwondo, Aikido (1)
- Tai Chi Chuan (1)
- Tape-Stripping-Methode (1)
- Therapie (1)
- Thermographie (1)
- Trainingsprogramm (1)
- Transkutane elektrische Nervenstimulation (TENS) (1)
- Treatment (1)
- Trigger-Point (1)
- Triggerpunkte (1)
- Tuina (1)
- UV-A radiation (1)
- UVA-Strahlung (1)
- Ulcus cruris venosum (1)
- Ultraviolett A (UVA) (1)
- Ultraviolett A1 (UVA1) (1)
- Validierungsstudie (1)
- Vergütung (1)
- Versorgungsforschung (1)
- Vertebroplastie (1)
- Warze (1)
- Warzen (1)
- Wassergefiltertes Infrarot A (1)
- Wellness (1)
- Welt-Anti-Doping-Agentur (1)
- Weltgesundheitsorganisation (WHO) (1)
- Weltverband für Sportmedizin (FIMS) (1)
- Wettbewerbsfelder (1)
- Wirbelgelenkblockaden (1)
- World Health Organisation (WHO) (1)
- Wundversorgung (1)
- Yoga (1)
- absent consumption of material (1)
- acupressure (1)
- acupuncture (1)
- allocation of resources (1)
- ambulante/praxisklinische Operationen (1)
- analgesic therapy (1)
- anatomic length difference of the legs (1)
- anatomische Beinlängendifferenz (1)
- anti-acidification, myofascial, myo-ischemic-acidotic, myotendinitic pain syndrome (1)
- assessments (1)
- ayurveda (1)
- ayurvedic medicine (1)
- ayurvedische Medizin (1)
- back pain (1)
- back training (1)
- behavior oriented training programs (1)
- bewegungs-/trainingstherapeutische Maßnahmen (1)
- brain (1)
- cPLA2 (1)
- children (1)
- chronic venous leg ulcers (1)
- cicatrisation (1)
- circulation sanguine tissulaire (1)
- claims data (1)
- clinical examination (1)
- competing purposes of use (1)
- competitive uses (1)
- computed tomography (CT) controlled procedures (1)
- conservative, interventional and operative procedures (1)
- control and regress mechanisms (1)
- corneometry (1)
- cost effectiveness analysis (1)
- curcumin (1)
- denervating procedures (1)
- denervierende Verfahren (1)
- dermatopharmacokinetics (1)
- deviations (1)
- diagnosebezogene Entgeltpauschalen (1)
- diagnosis-related fixed payments (1)
- diminution de la douleur (1)
- doppeltblinde Studien (1)
- dye (1)
- ear acupuncture (1)
- economy (1)
- endoscopic sequestrectomy (1)
- endoskopische Sequestrektomie (1)
- endurance training (1)
- ergometrische Leistungsfähigkeit (1)
- evaluation (1)
- evidence-based medicine (1)
- exsudat des plaies (1)
- financing (1)
- fitness center (1)
- fluorescein (1)
- flurbiprofen (1)
- function deficits (1)
- gesellschaftliche Zwänge (1)
- guidelines (1)
- health services research (1)
- healthcare industry (1)
- human capital (1)
- human papilloma virus (HPV) (1)
- humanes Papillomvirus (HPV) (1)
- hydration of the epidermis (1)
- hydrophil (1)
- hydrophilic, lipophilic, occlusive dressing (1)
- hyperbaric oxygen therapy (HBO) (1)
- hyperthermia (1)
- imaging (1)
- impaired statics (1)
- implant procedures (1)
- infrared whole body hyperthermia (1)
- infrared-A radiation (IR-A) (1)
- infrarouge filtré par l’eau (wIRA) (1)
- injection therapy (1)
- integrated ambulatory care (1)
- klinische Untersuchung (1)
- konkurrierende Verwendungszwecke (1)
- konservative, interventionelle und operative Verfahren (1)
- kontrollierte Studien (1)
- körperliches Training (1)
- lack of exercise (1)
- laser scanning microscopy (1)
- lifestyle change (1)
- lipophil (1)
- low back pain (1)
- magnetic field resonance therapy (1)
- manual therapy (1)
- manuelle Therapie (1)
- massage (chinese / japanese / ayurvedic / indian / indonesian / javanese / balinese massage) (1)
- matrix rhythm therapy (1)
- maximale Sauerstoffaufnahme (1)
- micro current therapy (1)
- microsurgical decompression (1)
- mikrochirurgische Dekompression (1)
- minimal invasive cervical and lumbar spondylodesis (1)
- minimal-invasive zervikale und lumbale Spondylodese (1)
- motion/training therapeutic procedures (1)
- multimodal therapy (1)
- multimodale Therapie (1)
- muscular dysbalances (1)
- muskuläre Dysbalancen (1)
- myocardial infarction (MI) (1)
- myofasziales, myo-ischämisch-azidotisches, myotendinitisches Schmerzsyndrom (1)
- neurochirurgische Praxisklinik (1)
- neurosurgery (1)
- neurosurgical clinics (1)
- nicht-thermische Effekte (1)
- offen-operative Verfahren (1)
- open operative procedures (1)
- outpatient procedures (1)
- oxygen (1)
- pathologic changes (1)
- pathologische Veränderungen (1)
- pathophysiology (1)
- pelvic obliquity (1)
- penetration (1)
- penetration enhancer (1)
- percutaneous laser disk decompression (1)
- perkutane LaserDiskus-Dekompression (1)
- pharmaceutical and medical remedies directives (1)
- pharmacoepidemiology (1)
- photoaging (1)
- photodynamic therapy (PDT) (1)
- physical medicine (1)
- physical training (1)
- physiotherapy (1)
- pression partielle en oxygène (1)
- preventive back school (1)
- preventive medicine (1)
- primary, secondary, tertiary prevention (1)
- primäre, sekundäre, tertiäre Prävention (1)
- prioritisation in medicine (1)
- prospective study (1)
- prospective, randomised, controlled, double-blinded studies (1)
- prospective, randomized, controlled, blinded study (1)
- prospektive Studie (1)
- prospektive Studien (1)
- prospektive, randomisierte, kontrollierte, verblindete Studie (1)
- präventive Rückenschule (1)
- psyche (1)
- psychotherapy (1)
- quality of lif (1)
- randomisierte Studien (1)
- rationalisation (1)
- rationing (1)
- reduction of hypersalivation (1)
- reduction of hypersecretion (1)
- reduction of mucus (1)
- remuneration (1)
- resistance to infection (1)
- scoliosis (1)
- shiatsu (1)
- skin barrier (1)
- skin surface temperature (1)
- social pressures (1)
- social security code (1)
- spectroscopy (1)
- sports pro health (1)
- standard service volumes (1)
- stratum corneum (1)
- stretching of shortened musculature (1)
- tape stripping method (1)
- température tissulaire (1)
- therapeutic regional anesthesia (1)
- therapeutische Lokalanästhesie (1)
- therapy (1)
- thermische Effekte (1)
- traditional chinese medicine (1)
- traditionelle chinesische Medizin (1)
- training program (1)
- transcutaneous electrical nerve stimulation (TENS) (1)
- transepidermal water loss (TEWL) (1)
- transepidermaler Wasserverlust (TEWL) (1)
- trigger points (1)
- tuina (1)
- ultraviolet-A (UV-A) (1)
- ultraviolet-A1 (UV-A1) (1)
- validation studies (1)
- verhaltensorientierte Trainingsprogramme (1)
- vertebral joint blockings (1)
- vertebroplasty (1)
- warts (1)
- wassergefiltertes Infrarot A (1)
- water-filtered infrared A (wIRA) (1)
- water-filtered infrared-A (1)
- water-filtered infrared-A (wIRA (1)
- waterfiltered infrared A (wIRA) (1)
- wound secretion (1)
- Ökonomie (1)
- Übertraining (1)
Institute
Wassergefiltertes Infrarot A (wIRA) bezeichnet eine spezielle Form der Infrarotstrahlung (Wärmestrahlung) im Bereich von 780 bis 1.400 nm, die aufgrund ihrer sehr guten Verträglichkeit in der Medizin zur Prävention und Therapie verwendet wird. wIRA steigert Temperatur, Sauerstoffpartialdruck und Durchblutung im Gewebe. Wesentliche klinische Wirkungen von wIRA sind – indikationsübergreifend – eine ausgeprägte Minderung von Schmerzen, Entzündung und vermehrter Flüssigkeitsabgabe sowie eine Verbesserung der Infektabwehr und der Regeneration.
The central portion of chronic wounds is often hypoxic and relatively hypothermic, representing a deficient energy supply of the tissue, which impedes wound healing or even makes it impossible. Water-filtered infrared-A (wIRA) is a special form of heat radiation with a high tissue penetration and a low thermal load to the skin surface. wIRA produces a therapeutically usable field of heat and increases temperature, oxygen partial pressure and perfusion of the tissue. These three factors are decisive for a sufficient tissue supply with energy and oxygen and consequently as well for wound healing, especially in chronic wounds, and infection defense. wIRA acts both by thermal and thermic as well as by non-thermal and non-thermic effects. wIRA can advance wound healing or improve an impaired wound healing process and can especially enable wound healing in non-healing chronic wounds. wIRA can considerably alleviate the pain and diminish wound exudation and inflammation and can show positive immunomodulatory effects.
In a prospective, randomized, controlled study of 40 patients with chronic venous stasis ulcers of the lower legs irradiation with wIRA and visible light (VIS) accelerated the wound healing process (on average 18 vs. 42 days until complete wound closure, residual ulcer area after 42 days 0.4 cm² vs. 2.8 cm²) and led to a reduction of the required dose of pain medication in comparison to the control group of patients treated with the same standard care (wound cleansing, wound dressing with antibacterial gauze, and compression garment therapy) without the concomitant irradiation.
Another prospective study of 10 patients with non-healing chronic venous stasis ulcers of the lower legs included extensive thermographic investigation. Therapy with wIRA(+VIS) resulted in a complete or almost complete wound healing in 7 patients and a marked reduction of the ulcer size in another 2 of the 10 patients, a clear reduction of pain and required dose of pain medication, and a normalization of the thermographic image.
In a current prospective, randomized, controlled, blinded study patients with non-healing chronic venous stasis ulcers of the lower legs are treated with compression garment therapy, wound cleansing, wound dressings and 30 minutes irradiation five times per week over 9 weeks. A preliminary analysis of the first 23 patients of this study has shown in the group with wIRA(+VIS) compared to a control group with VIS an advanced wound healing, an improved granulation and in the later phase of treatment a decrease of the bacterial burden.
Some case reports have demonstrated that wIRA can also be used for mixed arterial-venous ulcers or arterial ulcers, if irradiation intensity is chosen appropriately low and if irradiation is monitored carefully. wIRA can be used concerning decubital ulcers both in a preventive and in a therapeutic indication. wIRA can improve the resorption of topically applied substances also on wounds.
An irradiation with VIS and wIRA presumably acts with endogenous protoporphyrin IX (or protoporphyrin IX of bacteria) virtually similar as a mild photodynamic therapy (endogenous PDT-like effect). This could lead to improved cell regeneration and wound healing and to antibacterial effects.
In conclusion, these results indicate that wIRA generally should be considered for the treatment of chronic wounds.
Background: Common warts (verrucae vulgares) are human papilloma virus (HPV) infections with a high incidence and prevalence, most often affecting hands and feet, being able to impair quality of life. About 30 different therapeutic regimens described in literature reveal a lack of a single striking strategy. Recent publications showed positive results of photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) in the treatment of HPV-induced skin diseases, especially warts, using visible light (VIS) to stimulate an absorption band of endogenously formed protoporphyrin IX. Additional experiences adding waterfiltered infrared A (wIRA) during 5-ALA-PDT revealed positive effects. Aim of the study: First prospective randomised controlled blind study including PDT and wIRA in the treatment of recalcitrant common hand and foot warts. Comparison of "5-ALA cream (ALA) vs. placebo cream (PLC)" and "irradiation with visible light and wIRA (VIS+wIRA) vs. irradiation with visible light alone (VIS)". Methods: Pre-treatment with keratolysis (salicylic acid) and curettage. PDT treatment: topical application of 5-ALA (Medac) in "unguentum emulsificans aquosum" vs. placebo; irradiation: combination of VIS and a large amount of wIRA (Hydrosun® radiator type 501, 4 mm water cuvette, waterfiltered spectrum 590-1400 nm, contact-free, typically painless) vs. VIS alone. Post-treatment with retinoic acid ointment. One to three therapy cycles every 3 weeks. Main variable of interest: "Percent change of total wart area of each patient over the time" (18 weeks). Global judgement by patient and by physician and subjective rating of feeling/pain (visual analogue scales). 80 patients with therapy-resistant common hand and foot warts were assigned randomly into one of the four therapy groups with comparable numbers of warts at comparable sites in all groups. Results: The individual total wart area decreased during 18 weeks in group 1 (ALA+VIS+wIRA) and in group 2 (PLC+VIS+wIRA) significantly more than in both groups without wIRA (group 3 (ALA+VIS) and 4 (PLC+VIS)): medians and interquartile ranges: -94% (-100%/-84%) vs. -99% (-100%/-71%) vs. -47% (-75%/0%) vs. -73% (-92%/-27%). After 18 weeks the two groups with wIRA differed remarkably from the two groups without wIRA: 42% vs. 7% completely cured patients; 72% vs. 34% vanished warts. Global judgement by patient and by physician and subjective rating of feeling was much better in the two groups with wIRA than in the two groups without wIRA. Conclusions: The above described complete treatment scheme of hand and foot warts (keratolysis, curettage, PDT treatment, irradiation with VIS+wIRA, retinoic acid ointment; three therapy cycles every 3 weeks) proved to be effective. Within this treatment scheme wIRA as non-invasive and painless treatment modality revealed to be an important, effective factor, while photodynamic therapy with 5-ALA in the described form did not contribute recognisably - neither alone (without wIRA) nor in combination with wIRA - to a clinical improvement. For future treatment of warts an even improved scheme is proposed: one treatment cycle (keratolysis, curettage, wIRA, without PDT) once a week for six to nine weeks. © 2004 Fuchs et al; licensee German Medical Science. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL : http://www.egms.de/en/gms/volume2.shtml
Water-filtered infrared-A (wIRA) can act as a penetration enhancer for topically applied substances
(2008)
Background: Water-filtered infrared-A (wIRA) irradiation has been shown to enhance penetration of clinically used topically applied substances in humans through investigation of functional effects of penetrated substances like vasoconstriction by cortisone.
Aim of the study: Investigation of the influence of wIRA irradiation on the dermatopharmacokinetics of topically applied substances by use of optical methods, especially to localize penetrating substances, in a prospective randomised controlled study in humans.
Methods: The penetration profiles of the hydrophilic dye fluorescein and the lipophilic dye curcumin in separate standard water-in-oil emulsions were determined on the inner forearm of test persons by tape stripping in combination with spectroscopic measurements. Additionally, the penetration was investigated in vivo by laser scanning microscopy. Transepidermal water loss, hydration of the epidermis, and surface temperature were determined. Three different procedures (modes A, B, C) were used in a randomised order on three separate days of investigation in each of 12 test persons. In mode A, the two dyes were applied on different skin areas without water-filtered infrared-A (wIRA) irradiation. In mode B, the skin surface was irradiated with wIRA over 30 min before application of the two dyes (Hydrosun® radiator type 501, 10 mm water cuvette, orange filter OG590, water-filtered spectrum: 590–1400 nm with dominant amount of wIRA). In mode C, the two dyes were applied and immediately afterwards the skin was irradiated with wIRA over 30 min. In all modes, tape stripping started 30 min after application of the formulations. Main variable of interest was the ratio of the amount of the dye in the deeper (second) 10% of the stratum corneum to the amount of the dye in the upper 10% of the stratum corneum.
Results: The penetration profiles of the hydrophilic fluorescein showed in case of pretreatment or treatment with wIRA (modes B and C) an increased penetration depth compared to the non-irradiated skin (mode A): The ratio of the amount of the dye in the deeper (second) 10% of the stratum corneum to the amount of the dye in the upper 10% of the stratum corneum showed medians and interquartile ranges for mode A of 0.017 (0.007/0.050), for mode B of 0.084 (0.021/0.106), for mode C of 0.104 (0.069/0.192) (difference between modes: p=0.0112, significant; comparison mode A with mode C: p<0.01, significant). In contrast to fluorescein, the lipophilic curcumin showed no differences in the penetration kinetics, in reference to whether the skin was irradiated with wIRA or not. These effects were confirmed by laser scanning microscopy. Water-filtered infrared-A irradiation increased the hydration of the stratum corneum: transepidermal water loss rose from approximately 8.8 g m-2 h-1 before wIRA irradiation to 14.2 g m-2 h-1 after wIRA irradiation and skin hydration rose from 67 to 87 relative units. Skin surface temperature increased from 32.8°C before wIRA to 36.4°C after wIRA irradiation.
Discussion: The better penetration of the hydrophilic dye fluorescein after or during skin irradiation (modes B and C) can be explained by increased hydration of the stratum corneum by irradiation with wIRA.
Conclusions: As most topically applied substances for the treatment of patients are mainly hydrophilic, wIRA can be used to improve the penetration of substances before or after application of substances – in the first case even of thermolabile substances – with a broad clinical relevance as a contact free alternative to an occlusive dressing.
Water-filtered infrared-A (wIRA), as a special form of heat radiation with a high tissue penetration and a low thermal load to the skin surface, can improve the healing of acute and chronic wounds both by thermal and thermic as well as by non-thermal and non-thermic effects. wIRA increases tissue temperature (+2.7°C at a tissue depth of 2 cm), tissue oxygen partial pressure (+32% at a tissue depth of 2 cm) and tissue perfusion. These three factors are decisive for a sufficient supply of tissue with energy and oxygen and consequently also for wound healing and infection defense.
wIRA can considerably alleviate pain (without any exception during 230 irradiations) with substantially less need for analgesics (52–69% less in the groups with wIRA compared to the control groups). It also diminishes exudation and inflammation and can show positive immunomodulatory effects. The overall evaluation of the effect of irradiation as well as the wound healing and the cosmetic result (assessed on visual analogue scales) were markedly better in the group with wIRA compared to the control group. wIRA can advance wound healing (median reduction of wound size of 90% in severely burned children already after 9 days in the group with wIRA compared to 13 days in the control group; on average 18 versus 42 days until complete wound closure in chronic venous stasis ulcers) or improve an impaired wound healing (reaching wound closure and normalization of the thermographic image in otherwise recalcitrant chronic venous stasis ulcers) both in acute and in chronic wounds including infected wounds. After major abdominal surgery there was a trend in favor of the wIRA group to a lower rate of total wound infections (7% versus 15%) including late infections following discharge from hospital (0% versus 8%) and a trend towards a shorter postoperative hospital stay (9 versus 11 days).
Even the normal wound healing process can be improved.
The mentioned effects have been proven in six prospective studies, with most of the effects having an evidence level of Ia/Ib.
wIRA represents a valuable therapy option and can generally be recommended for use in the treatment of acute as well as of chronic wounds.
Background: Water-filtered infrared-A (wIRA) is a special form of heat radiation with a high tissue-penetration and with a low thermal burden to the surface of the skin. wIRA is able to improve essential and energetically meaningful factors of wound healing by thermal and non-thermal effects.
Aim of the study: prospective study (primarily planned randomised, controlled, blinded, de facto with one exception only one cohort possible) using wIRA in the treatment of patients with recalcitrant chronic venous stasis ulcers of the lower legs with thermographic follow-up.
Methods: 10 patients (5 males, 5 females, median age 62 years) with 11 recalcitrant chronic venous stasis ulcers of the lower legs were treated with water-filtered infrared-A and visible light irradiation (wIRA(+VIS), Hydrosun® radiator type 501, 10 mm water cuvette, water-filtered spectrum 550–1400 nm) or visible light irradiation (VIS; only possible in one patient). The uncovered wounds of the patients were irradiated two to five times per week for 30 minutes at a standard distance of 25 cm (approximately 140 mW/cm2 wIRA and approximately 45 mW/cm2 VIS). Treatment continued for a period of up to 2 months (typically until closure or nearly closure of the ulcer). The main variable of interest was “percent change of ulcer size over time” including complete wound closure. Additional variables of interest were thermographic image analysis, patient’s feeling of pain in the wound, amount of pain medication, assessment of the effect of the irradiation (by patient and by clinical investigator), assessment of feeling of the wound area (by patient), assessment of wound healing (by clinical investigator) and assessment of the cosmetic state (by patient and by clinical investigator). For these assessments visual analogue scales (VAS) were used.
Results: The study showed a complete or nearly complete healing of lower leg ulcers in 7 patients and a clear reduction of ulcer size in another 2 of 10 patients, a clear reduction of pain and pain medication consumption (e.g. from 15 to 0 pain tablets per day), and a normalization of the thermographic image (before the beginning of the therapy typically hyperthermic rim of the ulcer with relative hypothermic ulcer base, up to 4.5°C temperature difference). In one patient the therapy of an ulcer of one leg was performed with the fully active radiator (wIRA(+VIS)), while the therapy of an ulcer of the other leg was made with a control group radiator (only VIS without wIRA), showing a clear difference in favour of the wIRA treatment. All mentioned VAS ratings improved remarkably during the period of irradiation treatment, representing an increased quality of life. Failures of complete or nearly complete wound healing were seen only in patients with arterial insufficiency, in smokers or in patients who did not have venous compression garment therapy.
Discussion and conclusions: wIRA can alleviate pain considerably (with an impressive decrease of the consumption of analgesics) and accelerate wound healing or improve a stagnating wound healing process and diminish an elevated wound exudation and inflammation both in acute and in chronic wounds (in this study shown in chronic venous stasis ulcers of the lower legs) and in problem wounds including infected wounds. In chronic recalcitrant wounds complete healing is achieved, which was not reached before. Other studies have shown that even without a disturbance of wound healing an acute wound healing process can be improved (e.g. reduced pain) by wIRA.
wIRA is a contact-free, easily used and pleasantly felt procedure without consumption of material with a good penetration effect, which is similar to solar heat radiation on the surface of the earth in moderate climatic zones. Wound healing and infection defence (e.g. granulocyte function including antibacterial oxygen radical formation of the granulocytes) are critically dependent on a sufficient energy supply (and on sufficient oxygen). The good clinical effect of wIRA on wounds and also on problem wounds and wound infections can be explained by the improvement of both the energy supply and the oxygen supply (e.g. for the granulocyte function). wIRA causes as a thermal effect in the tissue an improvement in three decisive factors: tissue oxygen partial pressure, tissue temperature and tissue blood flow. Besides this non-thermal effects of infrared-A by direct stimulation of cells and cellular structures with reactions of the cells have also been described. It is concluded that wIRA can be used to improve wound healing, to reduce pain, exudation, and inflammation and to increase quality of life.
Water-filtered infrared-A (wIRA) as a special form of heat radiation with a high tissue penetration and with a low thermal load to the skin surface acts both by thermal and thermic as well as by non-thermal and non-thermic effects. wIRA produces a therapeutically usable field of heat in the tissue and increases tissue temperature, tissue oxygen partial pressure, and tissue perfusion. These three factors are decisive for a sufficient tissue supply with energy and oxygen and consequently as well for wound healing and infection defense.
wIRA can considerably alleviate the pain (with remarkably less need for analgesics) and diminish an elevated wound exudation and inflammation and can show positive immunomodulatory effects. wIRA can advance wound healing or improve an impaired wound healing both in acute and in chronic wounds including infected wounds. Even the normal wound healing process can be improved.
A prospective, randomized, controlled, double-blind study with 111 patients after major abdominal surgery at the University Hospital Heidelberg, Germany, showed with 20 minutes irradiation twice a day (starting on the second postoperative day) in the group with wIRA and visible light VIS (wIRA(+VIS), approximately 75% wIRA, 25% VIS) compared to a control group with only VIS a significant and relevant pain reduction combined with a markedly decreased required dose of analgesics: during 230 single irradiations with wIRA(+VIS) the pain decreased without any exception (median of decrease of pain on postoperative days 2-6 was 13.4 on a 100 mm visual analog scale VAS 0-100), while pain remained unchanged in the control group (p<0.001). The required dose of analgesics was 57-70% lower in the subgroups with wIRA(+VIS) compared to the control subgroups with only VIS (median 598 versus 1398 ml ropivacaine, p<0.001, for peridural catheter analgesia; 31 versus 102 mg piritramide, p=0.001, for patient-controlled analgesia; 3.4 versus 10.2 g metamizole, p=0.005, for intravenous and oral analgesia). During irradiation with wIRA(+VIS) the subcutaneous oxygen partial pressure rose markedly by approximately 30% and the subcutaneous temperature by approximately 2.7°C (both in a tissue depth of 2 cm), whereas both remained unchanged in the control group: after irradiation the median of the subcutaneous oxygen partial pressure was 41.6 (with wIRA) versus 30.2 mm Hg in the control group (p<0.001), the median of the subcutaneous temperature was 38.9 versus 36.4°C (p<0.001). The overall evaluation of the effect of irradiation, including wound healing, pain and cosmesis, assessed on a VAS (0-100 with 50 as indifferent point of no effect) by the surgeon (median 79.0 versus 46.8, p<0.001) or the patient (79.0 versus 50.2, p<0.001) was markedly better in the group with wIRA compared to the control group. This was also true for single aspects: Wound healing assessed on a VAS by the surgeon (median 88.6 versus 78.5, p<0.001) or the patient (median 85.8 versus 81.0, p=0.040, trend) and cosmetic result assessed on a VAS by the surgeon (median 84.5 versus 76.5, p<0.001) or the patient (median 86.7 versus 73.6, p=0.001). In addition there was a trend in favor of the wIRA group to a lower rate of total wound infections (3 of 46, approximately 7%, versus 7 of 48, approximately 15%, p=0.208) including late infections after discharge, caused by the different rate of late infections after discharge: 0 of 46 in the wIRA group and 4 of 48 in the control group. And there was a trend towards a shorter postoperative hospital stay: 9 days in the wIRA group versus 11 days in the control group (p=0.037). The principal finding of this study was that postoperative irradiation with wIRA can improve even a normal wound healing process.
A prospective, randomized, controlled, double-blind study with 45 severely burned children at the Children’s Hospital Park Schönfeld, Kassel, Germany, showed with 30 minutes irradiation once a day (starting on the first day, day of burn as day 1) in the group with wIRA and visible light VIS (wIRA(+VIS), approximately 75% wIRA, 25% VIS) compared to a control group with only VIS a markedly faster reduction of wound size. On the fifth day (after 4 days with irradiation) decision was taken, whether surgical debridement of necrotic tissue was necessary because of deeper (second degree, type b) burns (11 of 21 in the group with wIRA, 14 of 24 in the control group) or non-surgical treatment was possible (second degree, type a, burns). The patients treated conservatively were kept within the study and irradiated till complete reepithelialization. The patients in the group with wIRA showed a markedly faster reduction of wound area: a median reduction of wound size of 50% was reached already after 7 days compared to 9 days in the control group, a median reduction of wound size of 90% was already achieved after 9 days compared to 13 days in the control group. In addition the group with wIRA showed superior results till 3 months after the burn in terms of the overall surgical assessment of the wound, cosmesis, and assessment of effects of irradiation compared to the control group.
In a prospective, randomized, controlled study with 12 volunteers at the University Medical Center Charité, Berlin, Germany, within each volunteer 4 experimental superficial wounds (5 mm diameter) as an acute wound model were generated by suction cup technique, removing the roof of the blister with a scalpel and a sterile forceps (day 1). 4 different treatments were used and investigated during 10 days: no therapy, only wIRA(+VIS) (approximately 75% wIRA, 25% VIS; 30 minutes irradiation once a day), only dexpanthenol (= D-panthenol) cream once a day, wIRA(+VIS) and dexpanthenol cream once a day. Healing of the small experimental wounds was from a clinical point of view excellent with all 4 treatments. Therefore there were only small differences between the treatments with slight advantages of the combination wIRA(+VIS) and dexpanthenol cream and of dexpanthenol cream alone concerning relative change of wound size and assessment of feeling of the wound area. However laser scanning microscopy with a scoring system revealed differences between the 4 treatments concerning the formation of the stratum corneum (from first layer of corneocytes to full formation) especially on the days 5-7: fastest formation of the stratum corneum was seen in wounds treated with wIRA(+VIS) and dexpanthenol cream, second was wIRA(+VIS) alone, third dexpanthenol cream alone and last were untreated wounds. Bacterial counts of the wounds (taken every 2 days) showed, that wIRA(+VIS) and the combination of wIRA(+VIS) with dexpanthenol cream were able to inhibit the colonisation with physiological skin flora up to day 5 when compared with the two other groups (untreated group and group with dexpanthenol cream alone). At any investigated time, the amount of colonisation under therapy with wIRA(+VIS) alone was lower (interpreted as more suppressed) compared with the group with wIRA(+VIS) and dexpanthenol cream.
During rehabilitation after hip and knee endoprosthetic operations the resorption of wound seromas and wound hematomas was both clinically and sonographically faster and pain was reduced by irradiation with wIRA(+VIS).
wIRA can be used successfully for persistent postoperative pain e.g. after thoracotomy.
As perspectives for wIRA it seems clinically prudent to use wIRA both pre- and postoperatively, e.g. in abdominal and thoracic operations. wIRA can be used preoperatively (e.g. during 1-2 weeks) to precondition donor and recipient sites of skin flaps, transplants or partial-thickness skin grafts, and postoperatively to improve wound healing and to decrease pain, inflammation and infections at all mentioned sites. wIRA can be used to support routine pre- or intraoperative antibiotic administration or it might even be discussed to replace this under certain conditions by wIRA.
Principles and working mechanisms of water-filtered infrared-A (wIRA) in relation to wound healing
(2007)
The experience of the pleasant heat of the sun in moderate climatic zones arises from the filtering of the heat radiation of the sun by water vapor in the atmosphere of the earth. The filter effect of water decreases those parts of infrared radiation (most parts of infrared-B and -C and the absorption bands of water within infrared-A), which would cause – by reacting with water molecules in the skin – only an undesired thermal load to the surface of the skin. Technically water-filtered infrared-A (wIRA) is produced in special radiators, whose full spectrum of radiation of a halogen bulb is passed through a cuvette, containing water, which absorbs or decreases the described undesired wavelengths of the infrared radiation. Within infrared the remaining wIRA (within 780-1400 nm) mainly consists of radiation with good penetration properties into tissue and therefore allows – compared to unfiltered heat radiation – a multiple energy transfer into tissue without irritating the skin, similar to the sun’s heat radiation in moderate climatic zones. Typical wIRA radiators emit no ultraviolet (UV) radiation and nearly no infrared-B and -C radiation and the amount of infrared-A radiation in relation to the amount of visible light (380-780 nm) is emphasized.
Water-filtered infrared-A as a special form of heat radiation with a high tissue penetration and with a low thermal load to the skin surface acts both by thermal (related to heat energy transfer) and thermic (temperature depending, with a relevant change of temperature) as well as by non-thermal (without a relevant transfer of heat energy) and non-thermic (not depending on temperature, without a relevant change of temperature) effects. wIRA produces a therapeutically usable field of heat in the tissue and increases tissue temperature, tissue oxygen partial pressure, and tissue perfusion. These three factors are vital for a sufficient tissue supply with energy and oxygen. As wound healing and infection defense (e.g. granulocyte function including their antibacterial oxygen radical formation) depend decisively on a sufficient supply with energy and oxygen, one explanation for the good clinical effect of wIRA on wounds and wound infections can be the improvement of both the energy supply per time (increase of metabolic rate) and the oxygen supply. In addition wIRA has non-thermal and non-thermic effects, which are based on putting direct stimuli on cells and cellular structures.
wIRA can considerably alleviate the pain (with remarkably less need for analgesics) and diminish an elevated wound exudation and inflammation and can show positive immunomodulatory effects. wIRA can advance wound healing or improve an impaired wound healing both in acute and in chronic wounds including infected wounds. Even the normal wound healing process can be improved.
Keywords: water-filtered infrared-A (wIRA), infrared-A radiation, wound healing, thermal and non-thermal effects, thermic and non-thermic effects, energy supply, oxygen supply, tissue oxygen partial pressure, tissue temperature, tissue blood flow, reduction of pain, wound exudation, inflammation, immunomodulatory effects, acute wounds, chronic venous stasis ulcers of the lower legs, problem wounds, wound infections, infection defense, contact-free method, absent expenditure of material, quality of life, prospective, randomized, controlled, double-blind studies
Water-filtered infrared-A radiation (wIRA) is not implicated in cellular degeneration of human skin
(2007)
Background: Excessive exposure to solar ultraviolet radiation is involved in the complex biologic process of cutaneous aging. Wavelengths in the ultraviolet-A and -B range (UV-A and UV-B) have been shown to be responsible for the induction of proteases, e. g. the collagenase matrix metalloproteinase 1 (MMP-1), which are related to cell aging. As devices emitting longer wavelengths are widely used in therapeutic and cosmetic interventions and as the induction of MMP-1 by water-filtered infrared-A (wIRA) had been discussed, it was of interest to assess effects of wIRA on the cellular and molecular level known to be possibly involved in cutaneous degeneration.
Objectives: Investigation of the biological implications of widely used water-filtered infrared-A (wIRA) radiators for clinical use on human skin fibroblasts assessed by MMP-1 gene expression (MMP-1 messenger ribonucleic acid (mRNA) expression).
Methods: Human skin fibroblasts were irradiated with approximately 88% wIRA (780-1400 nm) and 12% red light (RL, 665-780 nm) with 380 mW/cm² wIRA(+RL) (333 mW/cm² wIRA) on the one hand and for comparison with UV-A (330-400 nm, mainly UV-A1) and a small amount of blue light (BL, 400-450 nm) with 28 mW/cm² UV-A(+BL) on the other hand. Survival curves were established by colony forming ability after single exposures between 15 minutes and 8 hours to wIRA(+RL) (340-10880 J/cm² wIRA(+RL), 300-9600 J/cm² wIRA) or 15-45 minutes to UV-A(+BL) (25-75 J/cm² UV-A(+BL)). Both conventional Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and quantitative real-time RT-PCR techniques were used to determine the induction of MMP-1 mRNA at two physiologic temperatures for skin fibroblasts (30°C and 37°C) in single exposure regimens (15-60 minutes wIRA(+RL), 340-1360 J/cm² wIRA(+RL), 300-1200 J/cm² wIRA; 30 minutes UV-A(+BL), 50 J/cm² UV-A(+BL)) and in addition at 30°C in a repeated exposure protocol (up to 10 times 15 minutes wIRA(+RL) with 340 J/cm² wIRA(+RL), 300 J/cm² wIRA at each time).
Results: Single exposure of cultured human dermal fibroblasts to UV-A(+BL) radiation yielded a very high increase in MMP-1 mRNA expression (11 ±1 fold expression for RT-PCR and 76 ±2 fold expression for real-time RT-PCR both at 30°C, 75 ±1 fold expression for real-time RT-PCR at 37°C) and a dose-dependent decrease in cell survival. In contrast, wIRA(+RL) did not produce cell death and did not induce a systematic increase in MMP-1 mRNA expression (less than twofold expression, within the laboratory range of fluctuation) detectable with the sensitive methods applied. Additionally, repeated exposure of human skin fibroblasts to wIRA(+RL) did not induce MMP-1 mRNA expression systematically (less than twofold expression by up to 10 consecutive wIRA(+RL) exposures and analysis with real-time RT-PCR).
Conclusions: wIRA(+RL) even at the investigated disproportionally high irradiances does not induce cell death or a systematic increase of MMP-1 mRNA expression, both of which can be easily induced by UV-A radiation. Furthermore, these results support previous findings of in vivo investigations on collagenase induction by UV-A but not wIRA and show that infrared-A with appropriate irradiances does not seem to be involved in MMP-1 mediated photoaging of the skin. As suggested by previously published studies wIRA could even be implicated in a protective manner.